Endius
This article was originally published in The Gray Sheet
Executive Summary
Clinical evaluation of the firm's endoscopic spinal fusion system shows the procedure reduces blood loss to 50 cc, compared to 800 cc in conventional spinal fusion surgery, company President and CEO Thomas Davison tells investors at the Deutsche Banc Alex. Brown meeting. The device gained 510(k) clearance in October, after which the privately held firm commenced trials to collect data supporting use of the less invasive procedure